Risks

High net debt to EBITDA and only modest interest coverage leave SEM more exposed than many healthcare peers if reimbursement or volume growth softens, constraining flexibility.

A current ratio near 1.1 suggests limited liquidity cushion versus better-capitalized peers, increasing sensitivity to operating volatility and refinancing conditions.

A 50-day cash conversion cycle, driven by 63 days of receivables, ties up working capital more than asset-light peers and can pressure cash generation.

Elevated leverage can amplify the impact of any margin compression from payer mix or labor inflation, while less levered peers retain more room to absorb shocks.

Opportunities

SEM's healthcare-services exposure supports recurring demand versus more cyclical peers, giving it a steadier revenue base if utilization trends remain stable.

The absence of inventory and a relatively simple working-capital profile versus product-heavy peers can support cash efficiency once receivables are collected faster.

If reimbursement and patient volumes remain resilient, the company can convert operating leverage into earnings growth more effectively than smaller peers with weaker scale.

Compared with more capital-intensive healthcare models, SEM's service orientation can preserve flexibility for growth initiatives if leverage is managed through steady cash generation.

Overall Score

SEM combines a relatively resilient healthcare demand profile with service-model advantages, but higher leverage and working-capital pressure keep peer-relative positioning only moderately favorable.